Fresenius SE & Co. KGaA is a low-risk healthcare holding company in Germany. With a diverse portfolio that includes a minority stake in Fresenius Medical Care, Fresenius SE is a key player in the healthcare industry. The company's Kabi segment specializes in intravenous drugs, nutrition products, and infusion therapies, while the Helios segment operates private hospitals in Germany and Spain. Vamed, another segment of the company, offers services ranging from healthcare facility construction to post-acute care rehabilitation. With an ESG score of 13.6, Fresenius SE demonstrates a strong commitment to environmental, sustainability, and governance practices.